Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Etoposide and Cyclophosphamide in Stage D0 Prostate Cancer
NCT00176605Phase 2Completed
- Sponsor
- Rutgers University
- Start
- May 2005
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide, cyclophosphamide in prostate cancer (PCa), sponsored by Rutgers University. Started May 2005; status: completed.
02
Drugs
etoposidecyclophosphamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00176605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176605.